Clinical Trial Update: A Phase 3 Study to Assess the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia [Phase 3]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 3 study evaluating pitolisant for safety and efficacy in adults with idiopathic hypersomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Hypersomnia

Drugs mentioned

• Pitolisant (pitolisant)

Snippet

Sponsor: Harmony Biosciences Management, Inc. | Conditions: Idiopathic Hypersomnia | Phase 3 | Status: COMPLETED